← Feed

PARMAR KUSH

SEC Form 4 insider
Entrada Therapeutics, Inc. ($TRDA)
1 thesis · first seen Aug 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TRDASEC Form 4bearish
PARMAR KUSH · Entrada Therapeutics, Inc. · 17h agono track record yet
Sold 155,255 @ $6.95 avg · $1,078,937 · 2026-08-06

Form 4: PARMAR KUSH sold TRDA

PARMAR KUSH (Director at Entrada Therapeutics, Inc.) reported an open-market sale of 155,255 shares of TRDA at an average $6.95, roughly $1,078,937, in a Form 4 filed 2026-08-10.

Now $7.22just now
1d—
3d—
1w—
1m—
3m—
6m—
1y—
View filing on SEC.gov →

End of results.